Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sergey Shityakov, Ekaterina V. Skorb, Carola Y. Förster, Thomas Dandekar
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2021-10-01
Colección:Frontiers in Chemistry
Materias:
scaffold search
approved drugs
drug repurposing
alzheimer's disease
chemical similarity
molecular modeling
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Ejemplares similares